![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
AN Tucker, SJ Vore and MI Luster
Acute exposure of adult mice to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) results in a selective suppression of proliferating cells of the immune system, including hematopoietic stem cells and B cells. Suppression of B cell-mediated or humoral immunity, in turn, results in altered host resistance to the parasite Plasmodium yoelii, a malaria model. Data presented in this study demonstrate a direct effect of TCDD on cultured lymphoctes resulting in a selective inhibition of the differentiation of B cells into antibody-secreting cells. A structure- activity study suggested that this inhibition was mediated by the Ah receptor. As previously defined by receptor binding studies in hepatic cytosol, active congeners were inhibitory, whereas inactive congeners were without effect. Using lymphocytes from congenic mice which differ only at the Ah locus, it was determined that the Ahbb-derived cells were inhibited by TCDD in vitro, whereas the Ahdd-derived cells were not. B cell differentiation thus provides a valuable model for understanding TCDD toxicity as well as the role of the Ah receptor in growth and differentiation.
This article has been cited by other articles:
|
|
 |
|
  O. J. BOWERS, K. B. SOMMERSTED, R. T. SOWELL, G. E. BOLING, W. H. HANNEMAN, R. G. TITUS, and G. K. DEKREY 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN (TCDD) REDUCES LEISHMANIA MAJOR BURDENS IN C57BL/6 MICE. Am J Trop Med Hyg, October 1, 2006; 75(4): 749 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Allan and D. H. Sherr Constitutive Activation and Environmental Chemical Induction of the Aryl Hydrocarbon Receptor/Transcription Factor in Activated Human B Lymphocytes Mol. Pharmacol., May 1, 2005; 67(5): 1740 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P. Lawrence and B. A. Vorderstrasse Activation of the Aryl Hydrocarbon Receptor Diminishes the Memory Response to Homotypic Influenza Virus Infection but Does Not Impair Host Resistance Toxicol. Sci., June 1, 2004; 79(2): 304 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. W. Sulentic, W. Zhang, Y. J. Na, and N. E. Kaminski 2,3,7,8-Tetrachlorodibenzo-p-dioxin, an Exogenous Modulator of the 3'{alpha} Immunoglobulin Heavy Chain Enhancer in the CH12.LX Mouse Cell Line J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 71 - 78. [Abstract] [Full Text]
|
|
|
|
|
|
B. S. Yoo, D. R. Boverhof, D. Shnaider, R. B. Crawford, T. R. Zacharewski, and N. E. Kaminski 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation of Pax5 in Lipopolysaccharide-Activated B Cells Toxicol. Sci., February 1, 2004; 77(2): 272 - 279. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. B. Crawford, C. E. W. Sulentic, B. S. Yoo, and N. E. Kaminski 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Regulation and Posttranslational Modification of p27kip1 in Lipopolysaccharide-Activated B Cells Toxicol. Sci., October 1, 2003; 75(2): 333 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. Landi, P. A. Bertazzi, A. Baccarelli, D. Consonni, S. Masten, G. Lucier, P. Mocarelli, L. Needham, N. Caporaso, and J. Grassman TCDD-mediated alterations in the AhR-dependent pathway in Seveso, Italy, 20 years after the accident Carcinogenesis, April 1, 2003; 24(4): 673 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. Luebke, C. B. Copeland, M. Daniels, A. L. Lambert, and M. I. Gilmour Suppression of Allergic Immune Responses to House Dust Mite (HDM) in Rats Exposed to 2,3,7,8-TCDD Toxicol. Sci., July 1, 2001; 62(1): 71 - 79. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Thurmond and T. A. Gasiewicz A Single Dose of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Produces a Time- and Dose-Dependent Alteration in the Murine Bone Marrow B-Lymphocyte Maturation Profile Toxicol. Sci., November 1, 2000; 58(1): 88 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Regulations and Advisories Toxicology and Industrial Health, April 1, 2000; 16(3-5): 173 - 201. [PDF]
|
|
|
|
 |
|
 D. L. Spencer, S. A. Masten, K. M. Lanier, X. Yang, J. A. Grassman, C. R. Miller, T. R. Sutter, G. W. Lucier, and N. J. Walker Quantitative Analysis of Constitutive and 2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Cytochrome P450 1B1 Expression in Human Lymphocytes Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 139 - 146. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Marcus, M. P. Holsapple, and N. E. Kaminski Lipopolysaccharide Activation of Murine Splenocytes and Splenic B Cells Increased the Expression of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Nuclear Translocator J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1113 - 1118. [Abstract] [Full Text]
|
|
|
|
|
|
R. B. Crawford, M. P. Holsapple, and N. E. Kaminski Leukocyte Activation Induces Aryl Hydrocarbon Receptor Up-Regulation, DNA Binding, and Increased Cyp1a1 Expression in the Absence of Exogenous Ligand Mol. Pharmacol., December 1, 1997; 52(6): 921 - 927. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. McConkey, P Hartzell, S. Duddy, H Hakansson, and S Orrenius 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation Science, October 14, 1988; 242(4876): 256 - 259. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
